1 |
Murohara, T., Asahara, T., Silver, M., Bauters, C., Masuda, H.,
Kalka, C., Kearney, M., Chen, D., Symes, J. F., Fishman, M.
C., Huang, P. L. and Isner, J. M. (1998). Nitric oxide
synthase modulates angiogenesis in response to tissue
ischemia. J. Clin. Invest. 101, 2567-2578.
DOI
|
2 |
Namkoong, S., Chung, B. H., Ha, K. S., Lee, H., Kwon, Y. G.
and Kim, Y. M. (2008). Microscopic technique for the detection
of nitric oxide-dependent angiogenesis in an animal
model. Methods Enzymol. 441, 393-402.
DOI
|
3 |
Nathan, C. (1992). Nitric oxide as a secretory product of
mammalian cells. FASEB J. 6, 3051-3064.
DOI
|
4 |
Nathan, C. (1997). Inducible nitric oxide synthase: what difference
does it make? J. Clin. Invest. 100, 2417-2423.
DOI
|
5 |
Nathan, C. and Xie, Q. W. (1994). Regulation of biosynthesis of
nitric oxide. J. Biol. Chem. 269, 13725-13728.
|
6 |
Papapetropoulos, A., Garcia-Cardena, G., Madri, J. A. and
Sessa, W. C. (1997). Nitric oxide production contributes to the
angiogenic properties of vascular endothelial growth factor in
human endothelial cells. J. Clin. Invest. 100, 3131- 139.
DOI
|
7 |
Lang, J. D. Jr., Teng, X., Chumley, P., Crawford, J. H., Isbell, T.
S., Chacko, B. K., Liu, Y., Jhala, N., Crowe, D. R., Smith, A.
B., Cross, R. C., Frenette, L., Kelley, E. E., Wilhite, D. W.,
Hall, C. R., Page, G. P., Fallon, M. B., Bynon, J. S., Eckhoff,
D. E. and Patel, R. P. (2007). Inhaled NO accelerates restoration
of liver function in adults following orthotopic liver
transplantation. J. Clin. Invest. 117, 2583-2591.
DOI
|
8 |
Le, X., Wei, D., Huang, S., Lancaster, J. R. Jr. and Xie, K.
(2005). Nitric oxide synthase II suppresses the growth and
metastasis of human cancer regardless of its up-regulation
of protumor factors. Proc. Natl. Acad. Sci. USA. 102, 8758-
8763.
DOI
|
9 |
Lee, P. C., Salyapongse, A. N., Bragdon, G. A., Shears, L. L.
2nd, Watkins, S. C., Edington, H. D. and Billiar, T. R. (1999).
Impaired wound healing and angiogenesis in eNOS-deficient
mice. Am. J. Physiol. 277, H1600-1608.
|
10 |
Li, J., Billiar, T. R., Talanian, R. V. and Kim, Y. M. (1997). Nitric
oxide reversibly inhibits seven members of the caspase
family via S-nitrosylation. Biochem. Biophys. Res. Commun.
240, 419-424.
DOI
|
11 |
Li, Q., Guo, Y., Xuan, Y. T., Lowenstein, C. J., Stevenson, S. C.,
Prabhu, S. D., Wu, W. J., Zhu, Y. and Bolli, R. (2003). Gene
therapy with inducible nitric oxide synthase protects against
myocardial infarction via a cyclooxygenase-2-dependent
mechanism. Circ. Res. 92, 741-748.
DOI
|
12 |
Lima, B., Forrester, M. T., Hess, D. T. and Stamler, J. S. (2010).
S-nitrosylation in cardiovascular signaling. Circ. Res. 106,
633-646.
DOI
|
13 |
Lowson, S. M. (2004). Alternatives to nitric oxide. Br. Med. Bull.
70, 119-131.
DOI
|
14 |
Marletta, M. A., Hurshman, A. R. and Rusche, K. M. (1998).
Catalysis by nitric oxide synthase. Curr. Opin. Chem. Biol. 2,
656-663.
DOI
|
15 |
Matthews, N. E., Adams, M. A., Maxwell, L. R., Gofton, T. E.
and Graham, C. H. (2001). Nitric oxide-mediated regulation
of chemosensitivity in cancer cells. J. Natl. Cancer Inst. 93,
1879-1885.
DOI
|
16 |
Kisley, L. R., Barrett, B. S., Bauer, A. K., Dwyer-Nield, L. D.,
Barthel, B., Meyer, A. M., Thompson, D. C. and Malkinson,
A. M. (2002). Genetic ablation of inducible nitric oxide
synthase decreases mouse lung tumorigenesis. Cancer
Res. 62, 6850-6856.
|
17 |
Kroncke, K. D., Fehsel, K. and Kolb-Bachofen, V. (1997). Nitric
oxide: cytotoxicity versus cytoprotection--how, why, when,
and where? Nitric Oxide. 1, 107-120.
DOI
|
18 |
Kiziltepe, T., Hideshima, T., Ishitsuka, K., Ocio, E. M., Raje, N.,
Catley, L., Li, C. Q., Trudel, L. J., Yasui, H., Vallet, S., Kutok,
J. L., Chauhan, D., Mitsiades, C. S., Saavedra, J. E., Wogan,
G. N., Keefer, L. K., Shami, P. J. and Anderson, K. C. (2007).
JS-K, a GST-activated nitric oxide generator, induces DNA
double-strand breaks, activates DNA damage response
pathways, and induces apoptosis in vitro and in vivo in
human multiple myeloma cells. Blood 110, 709-718.
DOI
|
19 |
Konopka, T. E., Barker, J. E., Bamford, T. L., Guida, E., Anderson,
R. L. and Stewart, A. G. (2001). Nitric oxide synthase II
gene disruption: implications for tumor growth and vascular
endothelial growth factor production. Cancer Res. 61,
3182-3187.
|
20 |
Kroncke, K. D. (2003). Nitrosative stress and transcription. Biol.
Chem. 384, 1365-1377.
DOI
|
21 |
Kumar, D., Branch, B. G., Pattillo, C. B., Hood, J., Thoma, S.,
Simpson, S., Illum, S., Arora, N., Chidlow, J. H., Jr., Langston,
W., Teng, X., Lefer, D. J., Patel, R. P. and Kevil, C. G.
(2008). Chronic sodium nitrite therapy augments ischemiainduced
angiogenesis and arteriogenesis. Proc. Natl. Acad.
Sci. USA. 105, 7540-7545.
DOI
|
22 |
Kuroki, I., Miyazaki, T., Mizukami, I., Matsumoto, N. and
Matsumoto, I. (2004). Effect of sodium nitroprusside on
ischemia-reperfusion injuries of the rat liver. Hepatogastroenterology
51, 1404-1407.
|
23 |
Lala, P. K. and Chakraborty, C. (2001). Role of nitric oxide in
carcinogenesis and tumour progression. Lancet Oncol. 2,
149-156.
DOI
|
24 |
Kanno, S., Lee, P. C., Zhang, Y., Ho, C., Griffith, B. P., Shears,
L. L. 2nd and Billiar, T. R. (2000). Attenuation of myocardial
ischemia/reperfusion injury by superinduction of inducible
nitric oxide synthase. Circulation 101, 2742-2748.
DOI
ScienceOn
|
25 |
Kim, Y. M., Chung, H. T., Simmons, R. L. and Billiar, T. R.
(2000). Cellular non-heme iron content is a determinant of
nitric oxide-mediated apoptosis, necrosis, and caspase
inhibition. J. Biol. Chem. 275, 10954-10961.
DOI
|
26 |
Kim, Y. M., Bergonia, H. and Lancaster, J. R. Jr. (1995a). Nitrogen
oxide-induced autoprotection in isolated rat hepatocytes.
FEBS Lett. 374, 228-232.
DOI
|
27 |
Kim, Y. M., Bergonia, H. A., Muller, C., Pitt, B. R., Watkins, W.
D. and Lancaster, J. R. Jr. (1995b). Loss and degradation of
enzyme-bound heme induced by cellular nitric oxide
synthesis. J. Biol. Chem. 270, 5710-5713.
DOI
|
28 |
Kim, Y. M., Chung, H. T., Kim, S. S., Han, J. A., Yoo, Y. M., Kim,
K. M., Lee, G. H., Yun, H. Y., Green, A., Li, J., Simmons, R.
L. and Billiar, T. R. (1999). Nitric oxide protects PC12 cells
from serum deprivation-induced apoptosis by cGMP-dependent
inhibition of caspase signaling. J. Neurosci. 19,
6740-6747.
DOI
|
29 |
Kim, Y. M., de Vera, M. E., Watkins, S. C. and Billiar, T. R.
(1997a). Nitric oxide protects cultured rat hepatocytes from
tumor necrosis factor-alpha-induced apoptosis by inducing
heat shock protein 70 expression. J. Biol. Chem. 272,
1402-1411.
DOI
|
30 |
Kim, Y. M., Talanian, R. V. and Billiar, T. R. (1997b). Nitric oxide
inhibits apoptosis by preventing increases in caspase-3-like
activity via two distinct mechanisms. J. Biol. Chem. 272, 31138-31148.
DOI
|
31 |
Kimura, H., Weisz, A., Kurashima, Y., Hashimoto, K., Ogura, T.,
D'Acquisto, F., Addeo, R., Makuuchi, M. and Esumi, H.
(2000). Hypoxia response element of the human vascular
endothelial growth factor gene mediates transcriptional
regulation by nitric oxide: control of hypoxia-inducible factor-
1 activity by nitric oxide. Blood 95, 189-197.
|
32 |
Johnson, T. A., Stasko, N. A., Matthews, J. L., Cascio, W. E.,
Holmuhamedov, E. L., Johnson, C. B. and Schoenfisch, M.
H. (2010). Reduced ischemia/reperfusion injury via glutathioneinitiated
nitric oxide-releasing dendrimers. Nitric Oxide 22,
30-36.
DOI
|
33 |
Huang, Z., Shiva, S., Kim-Shapiro, D. B., Patel, R. P., Ringwood,
L. A., Irby, C. E., Huang, K. T., Ho, C., Hogg, N., Schechter,
A. N. and Gladwin, M. T. (2005). Enzymatic function of
hemoglobin as a nitrite reductase that produces NO under
allosteric control. J. Clin. Invest. 115, 2099-2107.
DOI
|
34 |
Hunter, C. J., Dejam, A., Blood, A. B., Shields, H., Kim-Shapiro,
D. B., Machado, R. F., Tarekegn, S., Mulla, N., Hopper, A.
O., Schechter, A. N., Power, G. G. and Gladwin, M. T. (2004).
Inhaled nebulized nitrite is a hypoxia-sensitive NO-dependent
selective pulmonary vasodilator. Nat. Med. 10, 1122-
1127.
DOI
|
35 |
Ignarro, L. J., Buga, G. M., Wood, K. S., Byrns, R. E. and
Chaudhuri, G. (1987). Endothelium-derived relaxing factor
produced and released from artery and vein is nitric oxide.
Proc. Natl. Acad. Sci. USA. 84, 9265-9269.
DOI
|
36 |
Jones, S. P., Greer, J. J., Kakkar, A. K., Ware, P. D., Turnage,
R. H., Hicks, M., van Haperen, R., de Crom, R., Kawashima,
S., Yokoyama, M. and Lefer, D. J. (2004). Endothelial nitric
oxide synthase overexpression attenuates myocardial
reperfusion injury. Am. J. Physiol. Heart. Circ. Physiol. 286,
H276-282.
DOI
|
37 |
Jun, C. D., Choi, B. M., Hoon, R., Um, J. Y., Kwak, H. J., Lee, B.
S., Paik, S. G., Kim, H. M. and Chung, H. T. (1994).
Synergistic cooperation between phorbol ester and IFN- for
induction of nitric oxide synthesis in murine peritoneal
macrophages. J. Immunol. 153, 3684-3690.
|
38 |
Jung, K. H., Chu, K., Ko, S. Y., Lee, S. T., Sinn, D. I., Park, D.
K., Kim, J. M., Song, E. C., Kim, M. and Roh, J. K. (2006).
Early intravenous infusion of sodium nitrite protects brain
against in vivo ischemia-reperfusion injury. Stroke 37,
2744-2750.
DOI
|
39 |
Ghofrani, H. A., Hoeper, M. M., Halank, M., Meyer, F. J.,
Staehler, G., Behr, J., Ewert, R., Weimann, G. and
Grimminger, F. (2010). Riociguat for chronic thromboembolic
pulmonary hypertension and pulmonary arterial
hypertension: a phase II study. Eur. Respir. J. 36, 792-799.
DOI
ScienceOn
|
40 |
Gath, I., Closs, E. I., Godtel-Armbrust, U., Schmitt, S., Nakane,
M., Wessler, I. and Forstermann, U. (1996). Inducible NO
synthase II and neuronal NO synthase I are constitutively
expressed in different structures of guinea pig skeletal
muscle: implications for contractile function. FASEB J. 10,
1614-1620.
DOI
|
41 |
Granger, D. L., Taintor, R. R., Cook, J. L. and Hibbs, J. B. Jr.
(1980). Injury of neoplastic cells by murine macrophages
leads to inhibition of mitochondrial respiration. J. Clin. Invest.
65, 357-370.
DOI
|
42 |
Ha, K. S., Kim, K. M., Kwon, Y. G., Bai, S. K., Nam, W. D., Yoo,
Y. M., Kim, P. K., Chung, H. T., Billiar, T. R. and Kim, Y. M.
(2003). Nitric oxide prevents 6-hydroxydopamine-induced
apoptosis in PC12 cells through cGMP-dependent PI3
kinase/Akt activation. FASEB J. 17, 1036-1047.
DOI
|
43 |
Hibbs, J. B. Jr., Taintor, R. R. and Vavrin, Z. (1987). Macrophage
cytotoxicity: role for L-arginine deiminase and imino
nitrogen oxidation to nitrite. Science 235, 473-476.
DOI
|
44 |
Hibbs, J. B. Jr., Taintor, R. R., Vavrin, Z. and Rachlin, E. M. (1988).
Nitric oxide: a cytotoxic activated macrophage effector
molecule. Biochem. Biophys. Res. Commun. 157, 87-94.
DOI
|
45 |
Huang, L. E., Willmore, W. G., Gu, J., Goldberg, M. A. and
Bunn, H. F. (1999). Inhibition of hypoxia-inducible factor 1
activation by carbon monoxide and nitric oxide. Implications
for oxygen sensing and signaling. J. Biol. Chem. 274, 9038-
9044.
DOI
|
46 |
Huang, P. L., Huang, Z., Mashimo, H., Bloch, K. D., Moskowitz,
M. A., Bevan, J. A. and Fishman, M. C. (1995). Hypertension
in mice lacking the gene for endothelial nitric oxide synthase.
Nature 377, 239-242.
DOI
|
47 |
Forstermann, U., Kleinert, H., Gath, I., Schwarz, P., Closs, E. I.
and Dun, N. J. (1995). Expression and expressional control
of nitric oxide synthases in various cell types. Adv.
Pharmacol. 34, 171-186.
DOI
|
48 |
Fleming, I., Fisslthaler, B., Dimmeler, S., Kemp, B. E. and
Busse, R. (2001). Phosphorylation of Thr(495) regulates
Ca(2+)/calmodulin-dependent endothelial nitric oxide synthase
activity. Circ. Res. 88, E68-75.
DOI
|
49 |
Folkman, J. and Shing, Y. (1992). Angiogenesis. J. Biol. Chem.
267, 10931-10934.
|
50 |
Forrester, K., Ambs, S., Lupold, S. E., Kapust, R. B., Spillare, E.
A., Weinberg, W. C., Felley-Bosco, E., Wang, X. W., Geller,
D. A., Tzeng, E., Billiar, T. R. and Harris, C. C. (1996). Nitric
oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. Proc. Natl.
Acad. Sci. USA. 93, 2442-2447.
DOI
|
51 |
Foster, M. W., Hess, D. T. and Stamler, J. S. (2009). Protein
S-nitrosylation in health and disease: a current perspective.
Trends Mol. Med. 15, 391-404.
DOI
|
52 |
Fukumura, D., Gohongi, T., Kadambi, A., Izumi, Y., Ang, J.,
Yun, C. O., Buerk, D. G., Huang, P. L. and Jain, R. K. (2001).
Predominant role of endothelial nitric oxide synthase in
vascular endothelial growth factor-induced angiogenesis
and vascular permeability. Proc. Natl. Acad. Sci. USA. 98,
2604-2609.
DOI
|
53 |
Furchgott, R. F. and Zawadzki, J. V. (1980). The obligatory role
of endothelial cells in the relaxation of arterial smooth muscle
by acetylcholine. Nature 288, 373-376.
DOI
|
54 |
Garg, U. C. and Hassid, A. (1989). Nitric oxide-generating vasodilators
and 8-bromo-cyclic guanosine monophosphate
inhibit mitogenesis and proliferation of cultured rat vascular
smooth muscle cells. J. Clin. Invest. 83, 1774-1777.
DOI
|
55 |
Dulak, J., Jozkowicz, A., Dembinska-Kiec, A., Guevara, I.,
Zdzienicka, A., Zmudzinska-Grochot, D., Florek, I., Wojtowicz,
A., Szuba, A. and Cooke, J. P. (2000). Nitric oxide
induces the synthesis of vascular endothelial growth factor
by rat vascular smooth muscle cells. Arterioscler. Thromb.
Vasc. Biol. 20, 659-666.
DOI
ScienceOn
|
56 |
deRojas-Walker, T., Tamir, S., Ji, H., Wishnok, J. S. and Tannenbaum,
S. R. (1995). Nitric oxide induces oxidative damage
in addition to deamination in macrophage DNA. Chem. Res.
Toxicol. 8, 473-477.
DOI
|
57 |
Dezfulian, C., Raat, N., Shiva, S. and Gladwin, M. T. (2007).
Role of the anion nitrite in ischemia-reperfusion cytoprotection
and therapeutics. Cardiovasc. Res. 75, 327-338.
DOI
|
58 |
Dimmeler, S., Fleming, I., Fisslthaler, B., Hermann, C., Busse,
R. and Zeiher, A. M. (1999). Activation of nitric oxide
synthase in endothelial cells by Akt-dependent phosphorylation.
Nature 399, 601-605.
DOI
|
59 |
Duranski, M. R., Greer, J. J., Dejam, A., Jaganmohan, S., Hogg,
N., Langston, W., Patel, R. P., Yet, S. F., Wang, X., Kevil, C.
G., Gladwin, M. T. and Lefer, D. J. (2005). Cytoprotective
effects of nitrite during in vivo ischemia-reperfusion of the
heart and liver. J. Clin. Invest. 115, 1232-1240.
DOI
|
60 |
Edwards, C., Feng, H. Q., Reynolds, C., Mao, L. and Rockey, D.
C. (2008). Effect of the nitric oxide donor V-PYRRO/NO on
portal pressure and sinusoidal dynamics in normal and
cirrhotic mice. Am. J. Physiol. Gastrointest. Liver Physiol.
294, G1311-1317.
DOI
|
61 |
Elfering, S. L., Sarkela, T. M. and Giulivi, C. (2002). Biochemistry
of mitochondrial nitric-oxide synthase. J. Biol. Chem. 277,
38079-38086.
DOI
|
62 |
Elrod, J. W., Greer, J. J., Bryan, N. S., Langston, W., Szot, J. F.,
Gebregzlabher, H., Janssens, S., Feelisch, M. and Lefer, D.
J. (2006). Cardiomyocyte-specific overexpression of NO
synthase-3 protects against myocardial ischemia-reperfusion
injury. Arterioscler. Thromb. Vasc. Biol. 26, 1517-1523.
DOI
|
63 |
Chung, B. H., Lee, J. J., Kim, J. D., Jeoung, D., Lee, H., Choe,
J., Ha, K. S., Kwon, Y. G. and Kim, Y. M. (2010). Angiogenic
activity of sesamin through the activation of multiple signal
pathways. Biochem. Biophys. Res. Commun. 391, 254-260.
DOI
|
64 |
Chazotte-Aubert, L., Hainaut, P. and Ohshima, H. (2000). Nitric
oxide nitrates tyrosine residues of tumor-suppressor p53
protein in MCF-7 cells. Biochem. Biophys. Res. Commun.
267, 609-613.
DOI
|
65 |
Chinje, E. C. and Stratford, I. J. (1997). Role of nitric oxide in
growth of solid tumours: a balancing act. Essays Biochem.
32, 61-72.
|
66 |
Chung, B. H., Kim, J. D., Kim, C. K., Kim, J. H., Won, M. H., Lee,
H. S., Dong, M. S., Ha, K. S., Kwon, Y. G. and Kim, Y. M.
(2008). Icariin stimulates angiogenesis by activating the
MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways
in human endothelial cells. Biochem. Biophys. Res.
Commun. 376, 404-408.
DOI
|
67 |
Chung, H. T., Pae, H. O., Choi, B. M., Billiar, T. R. and Kim, Y.
M. (2001). Nitric oxide as a bioregulator of apoptosis.
Biochem. Biophys. Res. Commun. 282, 1075-1079.
DOI
|
68 |
Cosby, K., Partovi, K. S., Crawford, J. H., Patel, R. P., Reiter, C.
D., Martyr, S., Yang, B. K., Waclawiw, M. A., Zalos, G., Xu,
X., Huang, K. T., Shields, H., Kim-Shapiro, D. B., Schechter,
A. N., Cannon, R. O. 3rd and Gladwin, M. T. (2003). Nitrite
reduction to nitric oxide by deoxyhemoglobin vasodilates the
human circulation. Nat. Med. 9, 1498-1505.
DOI
|
69 |
Dash, P. R., Cartwright, J. E., Baker, P. N., Johnstone, A. P. and
Whitley, G. S. (2003). Nitric oxide protects human
extravillous trophoblast cells from apoptosis by a cyclic
GMP-dependent mechanism and independently of caspase
3 nitrosylation. Exp. Cell. Res. 287, 314-324.
DOI
|
70 |
Date, H., Triantafillou, A. N., Trulock, E. P., Pohl, M. S., Cooper,
J. D. and Patterson, G. A. (1996). Inhaled nitric oxide
reduces human lung allograft dysfunction. J. Thorac.
Cardiovasc. Surg. 111, 913-919.
DOI
|
71 |
Archer, S. L., Huang, J. M., Hampl, V., Nelson, D. P., Shultz, P.
J. and Weir, E. K. (1994). Nitric oxide and cGMP cause
vasorelaxation by activation of a charybdotoxin-sensitive K
channel by cGMP-dependent protein kinase. Proc. Natl.
Acad. Sci. USA. 91, 7583-7587.
DOI
|
72 |
Ahem, G. P., Klyachko, V. A. and Jackson, M. B. (2002). cGMP and S-nitrosylation: two routes for modulation of neuronal excitability by NO. Trends Neurosci. 25, 510-517.
DOI
|
73 |
Ahn, B. and Ohshima, H. (2001). Suppression of intestinal polyposis in Apc (Min/+) mice by inhibiting nitric oxide production. Cancer Res. 61, 8357-8360.
|
74 |
Andrade, S. P., Hart, I. R. and Piper, P. J. (1992). Inhibitors of nitric oxide synthase selectively reduce flow in tumorassociated neovasculature. Br. J. Pharmacol. 107, 1092-1095.
DOI
ScienceOn
|
75 |
Beghetti, M., Habre, W., Friedli, B. and Berner, M. (1995).
Continuous low dose inhaled nitric oxide for treatment of
severe pulmonary hypertension after cardiac surgery in
paediatric patients. Br. Heart J. 73, 65-68.
DOI
|
76 |
Bell, R. M., Maddock, H. L. and Yellon, D. M. (2003). The cardioprotective
and mitochondrial depolarising properties of
exogenous nitric oxide in mouse heart. Cardiovasc. Res. 57,
405-415.
DOI
|
77 |
Brune, B., von Knethen, A. and Sandau, K. B. (1998). Nitric
oxide and its role in apoptosis. Eur. J. Pharmacol. 351,
261-272.
DOI
|
78 |
Brune, B. and Zhou, J. (2007). Nitric oxide and superoxide:
interference with hypoxic signaling. Cardiovasc. Res. 75,
275-282.
DOI
|
79 |
Yerebakan, C., Ugurlucan, M., Bayraktar, S., Bethea, B. T. and
Conte, J. V. (2009). Effects of inhaled nitric oxide following
lung transplantation. J. Card. Surg. 24, 269-274.
DOI
|
80 |
Wei, D., Richardson, E. L., Zhu, K., Wang, L., Le, X., He, Y.,
Huang, S. and Xie, K. (2003). Direct demonstration of negative
regulation of tumor growth and metastasis by host-inducible
nitric oxide synthase. Cancer Res. 63, 3855-3859.
|
81 |
Yim, C. Y., Bastian, N. R., Smith, J. C., Hibbs, J. B. Jr. and
Samlowski, W. E. (1993). Macrophage nitric oxide synthesis
delays progression of ultraviolet light-induced murine skin
cancers. Cancer Res. 53, 5507-5511.
|
82 |
Ziche, M., Morbidelli, L., Choudhuri, R., Zhang, H. T., Donnini,
S., Granger, H. J. and Bicknell, R. (1997). Nitric oxide
synthase lies downstream from vascular endothelial growth
factor-induced but not basic fibroblast growth factor-induced
angiogenesis. J. Clin. Invest. 99, 2625-2634.
DOI
|
83 |
Yu, J., deMuinck, E. D., Zhuang, Z., Drinane, M., Kauser, K.,
Rubanyi, G. M., Qian, H. S., Murata, T., Escalante, B. and
Sessa, W. C. (2005). Endothelial nitric oxide synthase is
critical for ischemic remodeling, mural cell recruitment, and
blood flow reserve. Proc. Natl. Acad. Sci. USA. 102,
10999-11004.
DOI
|
84 |
Zech, B., Kohl, R., von Knethen, A. and Brune, B. (2003). Nitric
oxide donors inhibit formation of the Apaf-1/caspase-9
apoptosome and activation of caspases. Biochem. J. 371,
1055-1064.
DOI
|
85 |
Zhang, R., Wang, L., Zhang, L., Chen, J., Zhu, Z., Zhang, Z. and
Chopp, M. (2003). Nitric oxide enhances angiogenesis via
the synthesis of vascular endothelial growth factor and
cGMP after stroke in the rat. Circ. Res. 92, 308-313.
DOI
|
86 |
Surks, H. K. (2007). cGMP-dependent protein kinase I and
smooth muscle relaxation: a tale of two isoforms. Circ. Res.
101, 1078-1080.
DOI
|
87 |
Tatoyan, A. and Giulivi, C. (1998). Purification and characterization
of a nitric-oxide synthase from rat liver mitochondria.
J. Biol. Chem. 273, 11044-11048.
DOI
|
88 |
Taylor, C. T. and Moncada, S. (2010). Nitric oxide, cytochrome
C oxidase, and the cellular response to hypoxia. Arterioscler.
Thromb. Vasc. Biol. 30, 643-647.
DOI
|
89 |
Thatcher, G. R. (2005). An introduction to NO-related therapeutic
agents. Curr. Top. Med. Chem. 5, 597-601.
DOI
|
90 |
Thebaud, B., Arnal, J. F., Mercier, J. C. and Dinh-Xuan, A. T.
(1999). Inhaled and exhaled nitric oxide. Cell Mol. Life Sci.
55, 1103-1112.
DOI
|
91 |
Trikha, P., Sharma, N. and Athar, M. (2001). Nitroglycerin: a NO
donor inhibits TPA-mediated tumor promotion in murine skin.
Carcinogenesis 22, 1207-1211.
DOI
|
92 |
Tripatara, P., Patel, N. S., Webb, A., Rathod, K., Lecomte, F.
M., Mazzon, E., Cuzzocrea, S., Yaqoob, M. M., Ahluwalia, A.
and Thiemermann, C. (2007). Nitrite-derived nitric oxide
protects the rat kidney against ischemia/reperfusion injury in
vivo: role for xanthine oxidoreductase. J. Am. Soc. Nephrol.
18, 570-580.
DOI
|
93 |
Tsuchiya, K., Kanematsu, Y., Yoshizumi, M., Ohnishi, H., Kirima,
K., Izawa, Y., Shikishima, M., Ishida, T., Kondo, S., Kagami,
S., Takiguchi, Y. and Tamaki, T. (2005). Nitrite is an alternative
source of NO in vivo. Am. J. Physiol. Heart. Circ.
Physiol. 288, H2163-2170.
DOI
|
94 |
Webb, A., Bond, R., McLean, P., Uppal, R., Benjamin, N. and
Ahluwalia, A. (2004). Reduction of nitrite to nitric oxide during
ischemia protects against myocardial ischemia-reperfusion
damage. Proc. Natl. Acad. Sci. USA 101, 13683-13688.
DOI
|
95 |
Shimaoka, M., Iida, T., Ohara, A., Taenaka, N., Mashimo, T.,
Honda, T. and Yoshiya, I. (1995). NOC, a nitric-oxidereleasing
compound, induces dose dependent apoptosis in
macrophages. Biochem. Biophys. Res. Commun. 209,
519-526.
DOI
|
96 |
Silvagno, F., Xia, H. and Bredt, D. S. (1996). Neuronal nitric- oxide
synthase-mu, an alternatively spliced isoform expressed in
differentiated skeletal muscle. J. Biol. Chem. 271, 11204-11208.
DOI
|
97 |
Simeone, A. M., Colella, S., Krahe, R., Johnson, M. M., Mora, E.
and Tari, A. M. (2006). N-(4-Hydroxyphenyl)retinamide and
nitric oxide pro-drugs exhibit apoptotic and anti-invasive
effects against bone metastatic breast cancer cells.
Carcinogenesis 27, 568-577.
DOI
|
98 |
Stasch, J. P. and Hobbs, A. J. (2009). NO-independent, haemdependent
soluble guanylate cyclase stimulators. Handb.
Exp. Pharmacol. 277-308.
|
99 |
Sogawa, K., Numayama-Tsuruta, K., Ema, M., Abe, M., Abe, H.
and Fujii-Kuriyama, Y. (1998). Inhibition of hypoxia-inducible
factor 1 activity by nitric oxide donors in hypoxia. Proc. Natl.
Acad. Sci. USA. 95, 7368-7373.
DOI
|
100 |
Spedding, M., Schini, V., Schoeffter, P. and Miller, R. C. (1986).
Calcium channel activation does not increase release of
endothelial-derived relaxant factors (EDRF) in rat aorta
although tonic release of EDRF may modulate calcium
channel activity in smooth muscle. J. Cardiovasc. Pharmacol.
8, 1130-1137.
DOI
|
101 |
Steudel, W., Hurford, W. E. and Zapol, W. M. (1999). Inhaled
nitric oxide: basic biology and clinical applications. Anesthesiology
91, 1090-1121.
DOI
|
102 |
Stuehr, D. J. and Marletta, M. A. (1985). Mammalian nitrate
biosynthesis: mouse macrophages produce nitrite and
nitrate in response to Escherichia coli lipopolysaccharide.
Proc. Natl. Acad. Sci. USA. 82, 7738-7742.
DOI
|
103 |
Radomski, M. W., Jenkins, D. C., Holmes, L. and Moncada, S.
(1991). Human colorectal adenocarcinoma cells: differential
nitric oxide synthesis determines their ability to aggregate
platelets. Cancer Res. 51, 6073-6078.
|
104 |
RayChaudhury, A., Frischer, H. and Malik, A. B. (1996). Inhibition
of endothelial cell proliferation and bFGF-induced
phenotypic modulation by nitric oxide. J. Cell. Biochem. 63,
125-134.
DOI
|
105 |
Sase, K. and Michel, T. (1997). Expression and regulation of
endothelial nitric oxide synthase. Trends in Cardiovasc.
Med. 7, 28-37.
DOI
|
106 |
Schulz, R., Kelm, M. and Heusch, G. (2004). Nitric oxide in
myocardial ischemia/reperfusion injury. Cardiovasc. Res.
61, 402-413.
DOI
|
107 |
Scatena, R., Bottoni, P., Martorana, G. E. and Giardina, B.
(2005). Nitric oxide donor drugs: an update on pathophysiology
and therapeutic potential. Expert Opin. Investig.
Drugs 14, 835-846.
DOI
|
108 |
Schgoer, W., Theurl, M., Jeschke, J., Beer, A. G., Albrecht, K.,
Gander, R., Rong, S., Vasiljevic, D., Egger, M., Wolf, A. M.,
Frauscher, S., Koller, B., Tancevski, I., Patsch, J. R., Schratzberger,
P., Piza-Katzer, H., Ritsch, A., Bahlmann, F. H.,
Fischer-Colbrie, R., Wolf, D. and Kirchmair, R. (2009). Gene
therapy with the angiogenic cytokine secretoneurin induces
therapeutic angiogenesis by a nitric oxide-dependent mechanism.
Circ. Res. 105, 994-1002.
DOI
|
109 |
Schmidt, H. H., Lohmann, S. M. and Walter, U. (1993). The
nitric oxide and cGMP signal transduction system: regulation
and mechanism of action. Biochim. Biophys. Acta. 1178,
153-175.
DOI
|
110 |
Schwentker, A. and Billiar, T. R. (2002). Inducible nitric oxide
synthase: from cloning to therapeutic applications. World J.
Surg. 26, 772-778.
DOI
|
111 |
Messmer, U. K. and Brune, B. (1996). Nitric oxide-induced
apoptosis: p53-dependent and p53-independent signalling
pathways. Biochem. J. 319, 299-305.
DOI
|
112 |
Miller, M. R. and Megson, I. L. (2007). Recent developments in
nitric oxide donor drugs. Br. J. Pharmacol. 151, 305-321.
DOI
|
113 |
Moncada, S., Palmer, R. M. and Higgs, E. A. (1991). Nitric
oxide: physiology, pathophysiology, and pharmacology. Pharmacol.
Rev. 43, 109-142.
|
114 |
Murad, F. (1986). Cyclic guanosine monophosphate as a
mediator of vasodilation. J. Clin. Invest. 78, 1-5.
DOI
|